Quality indicators for the evaluation of patients with lung cancer

Chest

Volumn 146, Issue 3, 2014, Pages 659-669

  Mazzone, Peter J ^a   Vachani, Anil ^b   Chang, Andrew ^c   Detterbeck, Frank ^d   Cooke, David ^e   Howington, John ^f   Dodi, Amos ^c   Arenberg, Douglas ^c  

^a LERNER RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c UNIVERSITY OF MICHIGAN   (United States)

^d YALE UNIVERSITY   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f NORTHSHORE UNIVERSITY HEALTHSYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER STAGING; FEASIBILITY STUDY; HEALTH CARE DELIVERY; HEALTH CARE QUALITY; HEALTH SERVICE; HUMAN; LUNG CANCER; MEDICAL DOCUMENTATION; MEDICAL RECORD; MEDICAL SPECIALIST; PATIENT COUNSELING; SMOKING CESSATION; VALIDITY; CLINICAL TRIAL; EVIDENCE BASED PRACTICE; INFORMATION PROCESSING; LUNG NEOPLASMS; MOTIVATION; MULTICENTER STUDY; PATHOLOGY; PILOT STUDY; PRACTICE GUIDELINE; REPRODUCIBILITY; STANDARDS;

DATA COLLECTION; EVIDENCE-BASED PRACTICE; FEASIBILITY STUDIES; GOALS; GUIDELINES AS TOPIC; HUMANS; LUNG NEOPLASMS; NEOPLASM STAGING; PILOT PROJECTS; QUALITY INDICATORS, HEALTH CARE; REPRODUCIBILITY OF RESULTS;

EID: 84907194309     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.13-2900     Document Type: Article

References (30)

1. Mainz J. Defi ning and classifying clinical indicators for quality improvement. Int J Qual Health Care. 2003; 15 (6): 523-530.
2. Hermens RPMG, Ouwens MMTJ, Vonk-Okhuijsen SY, et al. Development of quality indicators for diagnosis and treatment of patients with non-small cell lung cancer: a first step toward implementing a multidisciplinary, evidence-based guideline. Lung Cancer. 2006; 54 (1): 117-124.
3. Lennes IT, Lynch TJ. Quality indicators in cancer care: development and implementation for improved health outcomes in non-small-cell lung cancer. Clin Lung Cancer. 2009; 10 (5): 341-346.
4. Tanvetyanon T. Quality-of-care indicators for non-small cell lung cancer. Cancer Contr. 2009; 16 (4): 335-341.
5. Malin JL, Asch SM, Kerr EA, McGlynn EA. Evaluating the quality of cancer care: development of cancer quality indicators for a global quality assessment tool. Cancer. 2000; 88 (3): 701-707.
6. Mainz J. Developing evidence-based clinical indicators: a state of the art methods primer. Int J Qual Health Care. 2003; 15(1-suppl): i5-i11.
7. Rivera MP, Mehta AC. Initial diagnosis of lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition). Chest. 2007;132(3-suppl):131S-148S.
8. Silvestri GA, Gould MK, Margolis ML, et al. Noninvasive staging of non-small cell lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition). Chest. 2007;132(3-suppl):178S-201S.
9. Detterbeck FC, Jantz MA, Wallace M, Vansteenkiste J, Silvestri GA. Invasive mediastinal staging of lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition). Chest. 2007;132(3-suppl):202S-220S.
10. Colice GL, Shafazand S, Griffin JP, Keenan R, Bolliger CT. Physiologic evaluation of the patient with lung cancer being considered for resectional surgery: ACCP evidence-based clinical practice guidelines (2nd edition). Chest. 2007;132(3-suppl):161S-177S.
11. Gould MK, Fletcher J, Iannettoni MD, et al. Evaluation of patients with pulmonary nodules: when is it lung cancer? ACCP evidence-based clinical practice guidelines (2nd edition). Chest. 2007:132(3-suppl):108S-130S.
12. Brunelli A, Charloux A, Bolliger CT, et al; European Respiratory Society and European Society of Thoracic Surgeons joint task force on fitness for radical therapy. ERS/ESTS clinical guidelines on fitness for radical therapy in lung cancer patients (surgery and chemo-radiotherapy). Eur Respir J. 2009; 34 (1): 17-41.
13. Lim E, Baldwin D, Beckles M, et al; British Thoracic Society; Society for Cardiothoracic Surgery in Great Britain and Ireland. Guidelines on the radical management of patients with lung cancer. Thorax. 2010; 65 (suppl 3): iii1-iii27.
14. NCCN guidelines for treatment of cancer by site. National Comprehensive Cancer Network website. http://www. nccn.org/professionals/physician-gls/f-guidelines.asp#site. Accessed March 15, 2012.
15. Crinò L, Weder W, van Meerbeeck J, Felip E; ESMO Guidelines Working Group. Early stage and locally advanced (non-metastatic) non-small-cell lung cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2010;21(suppl 5): v103-v115.
16. D'Addario G, Früh M, Reck M, Baumann P, Klepetko W, Felip E; ESMO Guidelines Working Group. Metastatic non-smallcell lung cancer: ESMO clinical practice guidelines for diagnosis, treatment and followup. Ann Oncol. 2010;21(suppl 5): v116-v119.
17. Sánchez de Cos J, Hernández JH, López MFJ, Sánchez SP, Gratacós AR, Porta RR; Sociedad Española Neumología y Cirugía Torácica. SEPAR guidelines for lung cancer staging. Arch Bronconeumol. 2011; 47 (9): 454-465.
18. Lung cancer: the diagnosis and treatment of lung cancer. National Institute for Health and Care Excellence website. http://publications.nice.org.uk/lung-cancercg121. Accessed March 15, 2012.
19. Mainz J, Hansen AM, Palshof T, Bartels PD. National quality measurement using clinical indicators: the Danish National Indicator Project. J Surg Oncol. 2009; 99 (8): 500-504.
20. Jakobsen E, Green A, Oesterlind K, Rasmussen TR, Iachina M, Palshof T. Nationwide quality improvement in lung cancer care: the role of the Danish Lung Cancer Group and Registry. J Thorac Oncol. 2013; 8 (10): 1238-1247.
21. Ouwens MMTJ, Hermens RR, Termeer RAR, et al. Quality of integrated care for patients with nonsmall cell lung cancer: variations and determinants of care. Cancer. 2007; 110 (8): 1782-1790.
22. Quality standard for lung cancer. National Institute for Health and Care Excellence website. http://publications. nice.org.uk/quality-standard-for-lungcancer-qs17. Accessed October 15, 2013.
23. Evans WK, Ung YC, Assouad N, Chyjek A, Sawka C. Improving the quality of lung cancer care in Ontario: the lung cancer disease pathway initiative. J Thorac Oncol. 2013; 8 (7): 876-882.
24. Katlic MR, Facktor MA, Berry SA, McKinley KE, Bothe A Jr, Steele GD Jr. ProvenCare lung cancer: a multiinstitutional improvement collaborative. CA Cancer J Clin. 2011; 61 (6): 382-396.
25. Cassivi SD, Allen MS, Vanderwaerdt GD, et al. Patient-centered quality indicators for pulmonary resection. Ann Thorac Surg. 2008; 86 (3): 927-932.
26. Schwarzbach M, Rössner E, Schattenberg T, Post S, Hohenberger P, Ronellenfitsch U. Effects of a clinical pathway of pulmonary lobectomy and bilobectomy on quality and cost of care. Langenbecks Arch Surg. 2010; 395 (8): 1139-1146.
27. Cerfolio RJ, Bryant AS. Optimal care of patients with non-small cell lung cancer reduces perioperative morbidity. J Thorac Cardiovasc Surg. 2011; 141 (1): 22-33.
28. National Quality Forum website. http://www.qualityforum.org/QPS/QPSTool. Accessed October 15, 2013.
29. Rivera MP, Mehta AC, Wahidi MM. Establishing the diagnosis of lung cancer: diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2013 (5-suppl): e142S-e165S.
30. Silvestri GA, Gonzalez AV, Jantz MA, et al. Methods for staging non-small cell lung cancer: diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidencebased clinical practice guidelines. Chest. 2013;143(5-suppl):e211S-e250S.